To examine how heat shock transcription factor 1 (HSF1) protects against maladaptive hypertrophy during pressure overload, we subjected HSF1 transgenic (TG), knockout (KO) and wild type (WT) mice to a constriction of transverse aorta (TAC), and found that cardiac hypertrophy, functions and angiogenesis were well preserved in TG mice but were decreased in KO mice compared to WT ones at 4 weeks, which was related to HIF-1 and p53 expression. Inhibition of angiogenesis suppressed cardiac adaptation in TG mice while overexpression of angiogenesis factors improved maladaptive hypertrophy in KO mice. In vitro formation of vasculatures by microvascular endothelial cells was higher in TG mice but lower in KO mice than in WT ones. A siRNA of p53 but not a HIF-1 gene significantly reversed maladaptive hypertrophy in KO mice whereas a siRNA of HIF-1 but not a p53 gene induced maladaptive hypertrophy in TG mice. Heart microRNA analysis showed that miR-378 and miR-379 were differently changed among the three mice after TAC, and miR-378 or siRNA of miR-379 could maintain cardiac adaptation in WT mice. These results indicate that HSF1 preserves cardiac adaptation during pressure overload through p53-HIF-1-associated angiogenesis, which is controlled by miR-378 and miR-379.
Introduction
Congestive heart failure is an end-stage of various heart diseases, which still accounts the reason for the high morbidity and mortality in many countries. However, the fundamental mechanisms of the development of heart failure have not yet been fully understood, thereby the potential strategies for the treatment of heart failure still need to be developed.
Heart failure is usually developed from a variety of heart diseases including cardiac hypertrophy 1 . Cardiac hypertrophy is the compensation for pressure overload 2 .
Also, it is often an adaptation to exercises 3 . Although pressure overload-induced cardiac hypertrophy may have beneficial effects at the beginning to maintain cardiac function, it would ultimately develop to heart failure at chronic stage 4 . However, exercise-induced cardiac hypertrophy could maintain the adaptive state and normal function without progression to heart failure 3, 5 . Recently, we have reported that heat shock transcription factor 1 (HSF1), an important transcription factor for heat shock proteins and one of the highly conserved protective factor, plays a critical role in exercise-induced adaptive cardiac hypertrophy in mice 6 . In the study, expression of HSF1 and its target molecule heat shock proteins was significantly upregulated in the heart by exercise but not by chronic pressure overload. HSF1 has protective roles against hypertrophy induced by chronic pressure overload in the HSF1 transgenic mice. Overexpression of HSF1 in the heart prevented cardiomyocyte death and myocardial fibrosis in response to sustained pressure overload, thereby preserved cardiac function, and decrease of expression of HSF1 in the heart impaired the adaptive response to exercise or acute pressure overload and thus caused cardiac dysfunction. On the other hand, it has been reported that transcription of HSPs by HSF1 may be directly activated by pressure overload in the heart in both in vitro and in vivo models, which plays an important role in myocardial protection against cardiac overload 7 . It has also been reported that HSF1 activation and HSP72 gene transcriptional competence during simulated exercise are linked to elevated heart temperature and are not a direct function of increased cardiac workload 8 . However, whether and how HSF1 could protect against the transition of an adaptive cardiac hypertrophy to heart failure during a permanent pressure overload is still unclear.
Recently, we showed in our another study that cardiac angiogenesis induced by HIF-1 is crucially involved in the adaptive mechanism of cardiac hypertrophy and that impairment of cardiac angiogenesis by p53 accumulation induces transition of the adaptive cardiac hypertrophy to heart failure 9 . These data collectively suggest that there is a relationship between HSF1-regulated protection of cardiac function and HIF-1/p53-related angiogenesis in myocardium. In the present study, using a permanent pressure overload model by constriction of the aorta (TAC) in the HSF1 transgenic (TG) or knockout (KO) mice and their littermate wild type (WT) mice, we demonstrated whether and how HSF1 preserves adaptation of the heart during a persistent cardiac workload.
Results

Overexpression of HSF1 enhanced cardiac hypertrophy and functions during pressure overload in mice
To begin investigating the role of HSF1 as a cardiac protective factor during pressure overload, we performed the operation of TAC in the WT, HSF1-TG and -KO adult mice and observed the development of cardiac hypertrophy and changes in cardiac functions for 4 weeks. These mice were apparently healthy, and there were no significant differences in the body weight (BW), heart weight to BW ratio (HW/BW), or hemodynamic parameters, such as blood pressure (BP), heart rate (HR) and left ventricle (LV) end-diastolic pressure (LVEDP), among the three type mice before the TAC 6, 10 (data not shown). After TAC, BP was elevated by 40~50 mmHg similarly in the three types of mice, which was persistent for 4 weeks. However, cardiac hypertrophy and functions analyzed by echocardiography, catheterization and histology were quite different among the three mice. After TAC, cardiac hypertrophy was more significantly formed in the TG mice (Fig. 1b) but less in the KO mice (Fig. 1c ) than in the WT ones (Fig. 1a) . Although cardiac function was well preserved in the TG mice for 4 weeks, it was significantly decreased at 4 weeks in the WT mice while at 2 weeks in the KO ones after TAC (Fig. 1d) . On the other hand, intercellular collagen content in myocardium was less in the TG mice but more in the KO mice than in WT mice after TAC (Fig. 1a-c) .
These results suggested that HSF1 could enhance adaptive hypertrophy and preserve cardiac functions during a permanent pressure overload.
Overexpression of HSF1 promoted cardiac angiogenesis after pressure overload
We next asked whether the role of HSF1 is associated with an increase in angiogenesis in myocardium after pressure overload since angiogenesis is important for the development of cardiac hypertrophy 9 . Immunohistochemical staining of myocardial sections with an anti factor VIII-related antigen (von Willebrand factor, vWF), which specifically expressed in endothelial cells, revealed that the densities of vWF-positive vasculatures were higher in the heart of TG mice but lower in the heart of KO mice than those in the heart of WT mice after TAC (Fig. 2a) , consisting with the results of cardiac hypertrophy.
Inhibition of angiogenesis with an inhibitor TNP-470, significantly suppressed TAC-induced cardiac hypertrophy in the TG mice (Fig. 2b) , while improving of angiogenesis by introducing the VEGF with Ang-1 genes into the heart of KO mice could increase hypertrophy after TAC (Fig. 2c) . These results indicated that the role of HSF1 in maintaining the adaptive cardiac hypertrophy during pressure overload is associated with angiogenesis.
HSF1 induced reprogramming of expression of HIF-1 and p53 in the heart during pressure overload
Since we have recently reported that HIF-1-regulated angiogenesis is important for the development of pressure overload-induced cardiac hypertrophy and that p53-induced inhibition of HIF-1 causes the transition from cardiac hypertrophy to heart failure 9 . We therefore asked whether HSF1 might induce angiogenesis through regulation of HIF-1 and p53 during pressure overload. There were no differences in expression of HIF-1 and p53 at basal condition before TAC (data not show). After TAC, consisting with our previous study 9 , expression of HIF-1 in WT heart was increased at early phase and decreased from 2 weeks after TAC, and expression of p53 was unchanged at early stage but elevated from 2 weeks after TAC (data not shown). However, expression of HIF-1 was much higher in the TG heart but lower in the KO heart than that in WT one at 4 weeks after TAC (Fig. 3a) . While expression of p53 was not increased in the TG heart until 4 weeks after TAC, but it showed a higher level in the KO heart after TAC as compared with WT one (Fig. 3b) . These results suggest that HSF1 could regulate the expression of HIF-1 and p53 in heart during pressure overload.
HSF1 regulated expression of HIF-1 through p53 during pressure overload
To further elucidate the roles of HIF-1 and p53 in HSF1-related adaptive hypertrophy during pressure overload, we introduced a HIF-1 gene or a small interfere RNA (siRNA)
of p53 into myocardium of the KO mice and a p53 gene or a siRNA of HIF-1 into myocardium of the TG mice, and performed TAC in these mice. Injection of the HIF1 gene into heart did not affect maladaptive state of the KO mice after TAC, whereas TAC could induce an adaptive hypertrophy in the KO mice after downregulation of p53 by the siRNA (Fig. 4a-c) , indicating that at the deficiency of HSF1, injection of an extrinsic HIF-1 gene could not exert roles while inhibition of the intrinsic p53 might function during TAC. In the TG mice, however, introducing a p53 gene into myocardium did not affect adaptive state after TAC, while TAC could induce a maladaptive hypertrophy after downregulation of HIF-1 by the siRNA (Fig. 4d-f ), indicating that in HSF1-overexpressing heart, effect of an extrinsic p53 gene was abolished but inhibition of HIF-1 by a siRNA was not interrupted. These results collectively suggest that HSF1-dependent effects on cardiac hypertrophy during TAC are relative to the regulation of p53 and HIF-1 and that HSF1 may regulate HIF-1 through p53.
Endothelial cells were involved in HSF1-ralated protection of the heart during pressure overload
Since angiogenesis was significantly involved in the development of cardiac hypertrophy, we therefore asked whether HSF1-regulated protection of heart during pressure overload miR-378 and mi-R379 were regulators for cardiac HSF1 during pressure overload.
To explore the reason for the suppression of HSF1 in myocardium after pressure overload, we employed a microRNA (miRNA) analysis in hearts of the WT, TG and KO mice after TAC for 2 weeks. Microarray showed 190 miRNAs significantly upregulated or downregulated in the WT heart after TAC, among which 10 were associated with the regulation of HSF1 (data not shown). Furthermore, among the 10 miRNAs, only the expression of miR-378 and miR-379 was not changed among the three types of hearts without TAC (Fig. 6a ). After TAC, however, miR-378 was decreased in hearts of both the WT and the KO but increased in the TG heart, while miR-379 was upregulated in hearts of both the WT and the KO but downregulated in the heart of TG mice ( To confirm the data of miRNA array, we examined the expression of miR-378 and miR-379 in hearts of the WT, TG and KO mice after TAC using Northern blot method.
Consisting with the results of miRNA array, miR-378 was decreased but miR-379 increased in the hearts of WT and KO mice, whereas miR-378 was increased but miR-379 decreased in heart of the TG mice ( Fig. 6b , left panels and c). We also examined the expression of miRNAs in human hearts, and also found that miR-378 was downregulated but miR-379 upregulated in the failing heart compared to the heart without failure (Fig.   6b , right panels).
miR-378 and siRNA of miR-379 benefited the pressure-overloaded hearts
To test whether overexpression of miR-378 or inhibition of miR-379 could ameliorated a maladaptive cardiac hypertrophy, we transfected the miR-378 or a siRNA of miR-379
into the myocardium of WT mice at 2 weeks after TAC and observed the development of cardiac hypertrophy and heart functions for another 2 weeks. At 4 weeks after TAC, the mice injected with miR-378 or siRNA of miR-379 showed a preserved cardiac hypertrophy and heart functions (Fig 6d) , which was similar to those in the HSF1 TG mice. Also, cardiac angiogenesis and HSF1 expression was significantly increased in myocardium of the miR-378 or siRNA of miR-379-transfected mice compared to those without the transfection (Fig. 6d, e) . These results strongly suggest that miR-378 and miR-379 are regulators for HSF1 in the heart and that upregulation of miR-378 or downregulation of miR-379 can ameliorate the maladaptive cardiac hypertrophy during pressure overload.
Discussion
Transition of the adaptive cardiac hypertrophy to a maladaptive one during hypertension is an important point to the development of heart failure 1, 2, 4, 9 . It is therefore necessary to explore a effective method to arrest the transition. In the present study, we found that overexpression of HSF1 in the heart preserved adaptive hypertrophy and cardiac function through maintenance of cardiac angiogenesis during pressure overload; HSF1 upregulated HIF-1 through downregulation of p53; miR-378/miR-379 were involved in the regulation of HSF1 in pressure-overloaded heart in mice.
Although pressure overload-induced cardiac hypertrophy usually develops to heart failure eventually, exercise-induced cardiac hypertrophy does not 3, 5 . We have recently reported that the prolonged adaptive state of exercise-induced cardiac hypertrophy is regulated by HSF1 and HSPs, and that HSF1-TG mice do not develop to maladaptive cardiac hypertrophy under chronic pressure overload 6 . In the present study, we also showed that under a persistent pressure overload, overexpression of the HSF1 in mice heart enhanced cardiac hypertrophy and delayed cardiac dysfunctions, while decrease of HSF1 impaired adaptive cardiac hypertrophy and aggravated cardiac dysfunctions. However, the mechanism of how HSF1exerts on the heart has been still unclear although the protection of cardiomyocytes from death has been speculated 6 . We recently observed that inhibition of angiogenesis causes transition of an adaptive hypertrophy to cardiac dysfunctions during pressure overload 9 and that increases in cardiomyocyte death evaluated by a TUNEL method was observed from 2 weeks but not at early phase after pressure overload (unpublished data), suggesting that angiogenesis may play a role in protection of the heart by HSF1. In our present results, angiogenesis was significantly more in the heart of HSF1 TG mice but less in the heart of HSF1 KO mice compared to WT heart after TAC. The changes of angiogenesis are paralleled to those of cardiac functions. Inhibition of angiogenesis by an inhibitor abolished preservation of cardiac adaptation in the HSF1 TG mice, while overexpression of angiogenic factors in the heart of HSF1 KO mice improved maladaptive hypertrophy under pressure overload. These results collectively show a pivotal role of angiogenesis in the beneficial effect of HSF1 on a workloaded heart.
HIF-1, a key transcription factor for the hypoxic induction of angiogenesis factors, can induce adaptive metabolic change as well as VEGF-mediated angiogenesis, which lead to the formation of new vessels 11, 12 . In the previous study, upregulation of HIF-1 expression and activation has been indicated to be important for the adaptive mechanism of cardiac hypertrophy at early phase during pressure overload 9 . In the present study, expression of HIF-1 was higher in the TG heart but lower in the KO heart compared to the WT one after TAC, suggesting that HSF1 may affect expression of HIF-1. However, overexpression of the HIF-1 in the heart lacking HSF1 did not benefit the maladaptive hypertrophy after TAC although overexpression of its downstream factors Ang-1 and VEGF did improve the cardiac functions in the same type of mice, indicating that there might be another mechanism existing in the HSF1 KO heart to suppress the effect of HIF-1 but not that of its downstream factors during pressure overload. It has been reported that HSF1 can act as a modifier of tumorigenesis through regulation of p53, which is required for tumor initiation and maintenance in a variety of cancer models 13 . It has also been indicated that p53 plays a critical role in the inhibition of adaptive upregulation of HIF-1 and angiogenesis during a chronic pressure overload 9 , which induces transition of cardiac hypertrophy to dysfunctions. In the present study, expression of p53 was significantly downregulated in the HSF1 TG heart but significantly upregulated in the KO one, while expression of HIF-1 was significantly upregulated in the HSF1 TG heart but downregulated in the KO one. Transfection of a siRNA into myocardium to knockdown the expression of p53 rather than overexpression of a HIF-1 gene significantly reversed the maladaptive hypertrophy in the KO mice whereas introduction of a siRNA of HIF-1 but not a p53 gene into the TG heart did worse the adaptive hypertrophy after TAC. These results collectively indicate that HSF1 exerts effects on the cardiac angiogenesis after pressure overload through suppression of p53
and thereby upregulating HIF-1, which leads to the adaptation maintenance of the pressure-overloaded heart.
It has been indicated that HSF1-regulated protection of heart is due to a direct protection of cardiomyocytes from death 6, 10, 14 . Sakamoto et al. indicated that the number of cardiomyocyte apoptosis was significantly less in the heart of HSF1 TG mice compared with that of WT mice after pressure overload and that expression of transforming growth factor was markedly increased in the heart after pressure overload but was significantly prevented by overexpression of HSF1 6 . It is therefore thought that HSF1 prevents cardiomyocyte death by antagonizing the proinflammatory pathways, thereby preventing the transition from adaptive to maladaptive hypertrophy. Since angiogenesis also accounts for the development of cardiac hypertrophy 9 , we therefore cultured MEC of hearts. Expression of HIF-1 and that of p53 were significantly observed in the MEC, but they were nearly undetectable in cardiomyocytes from the HSF1 TG and the KO mice even after mechanical stretch (unpublished data). Meanwhile, the vasculature formation was more significantly by the MEC of TG mice but less by the MEC of KO mice, whereas hypertrophic responses induced by mechanical stretch were similar between the two types of cardiomyocytes. These results collectively indicate that HSF1-associated long-term maintenance of adaptive cardiac hypertrophy is regulated by the MEC rather than by cardiomyocytes. These results also suggest a proper target cell for the treatment of heart failure.
It remains unclear how HSF1 is downregulated under sustained pressure overload.
Extracellular signal-regulated protein kinase (ERK) may increase HSF1 activity and participate in the activation of HSF1 in exercise-induced hypertrophy 6 . However, ERK has usually been known to be involved in abnormal growth of cells including pathological cardiac hypertrophy 15 . miRNAs are naturally existing, small, noncoding RNA molecules that downregulate posttranscriptional gene expression 16 . Their expression pattern and function in the heart has been recently demonstrated [17] [18] [19] [20] [21] . It has been shown that miRNAs play essential regulatory roles in the development of cardiac hypertrophy and that downregulation of miR-1 is necessary for the relief of growth-related target genes from its repressive influence and induction of hypertrophy [17] [18] [19] . It has also been reported that miR-133, which belongs to the same transcriptional unit to miR-1 and is decreased in mouse and human models of cardiac hypertrophy, has a critical role in determining cardiomyocyte hypertrophy 20 . However, these miRNAs are muscle relative that do not regulate cardiac angiogenesis. To explore the miRNAs targeting HSF1and angiogenesis in the heart, we performed a miRNA array of hearts in the HSF1 TG, KO and WT mice after TAC for 2 weeks when transition of the adaptive hypertrophy to the maladaptive one initiates naturally 9 . Among the significantly changed miRs relative to HSF1, miR-378 was lower in the WT and KO but higher in the TG heart, whereas miR-379 was higher in the WT and KO but lower in the TG heart, which is consistent with or contrast to the transcription levels of HSF1 in the heart, respectively.
miR-378 has been reported to enhance cell survival, tumor growth, and angiogenesis through repression of the expression of two tumor suppressors, Sufu and Fus-1 22 .
miR-379 has been indicated to play an important role in neurogenesis in the placental mammals 23 . However, the role of them in the regulation of cardiovascular diseases has not yet been reported. Here, introduction of the miR-378 or siRNA of miR-379 into myocardium of the WT mice resulted in an upregulation of HSF1 and angiogenesis, and a preservation of cardiac adaptation. These results indicate that miR-378 and miR-379 are also regulators for expression of HSF1 during mechanical stresses and that they may be as target molecules to interrupt the transition of an adaptive cardiac hypertrophy to a maladaptive one. Future study will focus on how miR-378 and miR-379 regulate HSF1
and whether there is a relationship between the two miRs in the regulation of HSF1.
In summary, we observed that overexpression of the HSF1 in heart of mice induced an improvement of angiogenesis through downregulation of p53 and subsequent upregulation of HIF-1, leading to a preservation of adaptive hypertrophy and cardiac functions and that miR-378 and miR-379 were involved in the regulation of HSF1 expression in heart during a persistent pressure overload. Although further studies are required, upregulation of HSF1 by promotion of miR-378 and/or inhibition of miR-379 in the heart may be a novel therapeutic strategy for preventing the transition from adaptive cardiac hypertrophy to heart failure.
Methods
Mice. Generation of the HSF1 TG and KO mice has been previously described 24, 25 .
Twelve-week-old male TG, KO and WT mice were used. There were no significant Pressure-overload model. Strong pressure overload was imposed on the heart of mice by TAC operation as described previously 9 . In brief, mice were anesthetized by intraperitoneal injection of a cocktail of ketamine HCl (100 mg/kg) and xylazine (5 mg/kg) and artificially ventilated using a respirator. The transverse aorta was constricted together with a blunted 27-gauge needle, which was pulled out later. and those in TAC groups with significant elevation of BP (40~50 mmHg) were enclosed.
Low-molecular-weight RNA was isolated from cardiac tissue by using the mirVana miRNA Isolation Kit (Ambion, Austin, TX). RNA from three animals in each group was pooled and used for miRNA expression analysis by using the miRMAX microarray. A total of 186 miRNAs examined showed comparable relative expression at baseline. The miRNAs without changes among the WT, HSF-1 TG and the KO hearts subjected to sham operation were selected for comparison. Differentially regulated miRNAs were defined as those with either < 0.5-or > 1.5-fold changes in expression compared the expression levels of sham hearts with TAC ones.
Northern blotting. Total RNA was extracted from heart tissues using TRIzol reagent according to the protocol of the manufacturer (Invitrogen). To aid analysis of miRNA, polyethylene glycol was applied to remove large-sized RNA. Nothern blot analysis was performed as described elsewhere 26 . The microRNA Detection Probes of miR-378 and miR-379 were obtained from miRCURY LNA™ . The probes were 5'-end labeled with biotin using miRNA probe and marker kit and used for hybridization.
Human heart tisssues. We obtained the human heart tissues from the Zhongshan Hospital, Fudan University under the procedures approved by the Ethnic Committee for
Use of Human Samples of the Fudan University. The LV tissues were from two rejected hearts of healthy persons during heart transplantation and from two explanted hearts of patients with end stage of heart failure.
Echocardiography. Transthoracic echocardiography was performed using an animal specific instrument (VisualSonics Vevo770, VisualSonics Inc. Canada) 6, 9 . Mice were weakly anesthetized and M-mode images of the LV were recorded when the mice partially recovered from anesthesia. All measurements were averaged for three consecutive cardiac cycles and were carried out by three experienced technicians who were unaware of the identities of the respective experimental groups. Histological analysis. Heart tissues were fixed in 10% formalin and embedded in paraffin or frozen in cryomolds, sectioned at 4 μm thickness and stained with hematoxylin and eosin (H-E) for histological examination, Masson trichrome for fibrosis and anti vWF for vascular endothelial cells, respectively. Digital photographs were taken at magnification x25, x100, x400, x1000, respectively. For measurement, five random high-power fields from each section were chosen and quantified in a blinded manner. The extent of fibrosis and the densities of vasculatures were measured in 5 sections from each heart and the value was expressed as the ration of Masson trichrome stained area to total LV wall or as the number of blood vessels/mm 2 , respectively.
Reverse transcription-polymerase chain reaction (RT-PCR) analysis. Total RNA was isolated from the heart tissues or cells using TRIzol reagent (15596-018, Gibco BRL).
The expression of the relative mRNA levels was evaluated using RT-PCR. The PCR products were subject to electrophoresis on 1.5% agarose gels, scanned, and semi-quantitated using Image-Quant software (Kodak 1D V3.53; Kodak, New Haven).
Statistics. Data are presented as mean ± S.E.M. Multiple group comparison was performed by one-way ANOVA followed by LSD procedure for comparison of means.
Comparison between 2 groups under identical conditions was performed by the 2-tailed Student't test. A value of p < 0.05 was considered statistically significant. However, LV wall was thicker, cavity was smaller and fibrosis was less in the TG mice whereas LV wall was thinner, cavity was larger, and fibrosis was more in the KO mice than in WT mice. At 4 weeks, LV wall thickness was decreased, cavity was enlarged and myocardial fibrosis was increased compared to those at 2 weeks in WT mice. All these changes were less in TG mice but more in the KO mice. was examined using total RNA of heart tissues from mice as in a (left) and human (right).
tRNA was used as loading control. Representative photograms from three independent experiments are shown. NH, heart of human without heart failure; FH, heart of human with heart failure. Western blot (bottom) analyses for HSF1 in heart of mice as in d. GAPDH and α-actin were used as loading controls for RT-PCR and Western blotting, respectively.
